BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25320013)

  • 1. EGFR activation and signaling in cancer cells are enhanced by the membrane-bound metalloprotease MT4-MMP.
    Paye A; Truong A; Yip C; Cimino J; Blacher S; Munaut C; Cataldo D; Foidart JM; Maquoi E; Collignon J; Delvenne P; Jerusalem G; Noel A; Sounni NE
    Cancer Res; 2014 Dec; 74(23):6758-70. PubMed ID: 25320013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of MT4-MMP, EGFR, and RB in Triple-Negative Breast Cancer Strongly Sensitizes Tumors to Erlotinib and Palbociclib Combination Therapy.
    Foidart P; Yip C; Radermacher J; Blacher S; Lienard M; Montero-Ruiz L; Maquoi E; Montaudon E; Château-Joubert S; Collignon J; Coibion M; Jossa V; Marangoni E; Noël A; Sounni NE; Jerusalem G
    Clin Cancer Res; 2019 Mar; 25(6):1838-1850. PubMed ID: 30504427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MT4-MMP and EGFR expression levels are key biomarkers for breast cancer patient response to chemotherapy and erlotinib.
    Yip C; Foidart P; Somja J; Truong A; Lienard M; Feyereisen E; Schroeder H; Gofflot S; Donneau AF; Collignon J; Delvenne P; Sounni NE; Jerusalem G; Noël A
    Br J Cancer; 2017 Mar; 116(6):742-751. PubMed ID: 28196064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of internalization and recycling of the prometastatic membrane type 4 matrix metalloproteinase (MT4-MMP) in breast cancer cells.
    Truong A; Yip C; Paye A; Blacher S; Munaut C; Deroanne C; Noel A; Sounni NE
    FEBS J; 2016 Feb; 283(4):704-22. PubMed ID: 26663028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MT4-MMP promotes invadopodia formation and cell motility in FaDu head and neck cancer cells.
    Yan X; Cao N; Chen Y; Lan HY; Cha JH; Yang WH; Yang MH
    Biochem Biophys Res Commun; 2020 Feb; 522(4):1009-1014. PubMed ID: 31813546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and Characterization of Membrane-Type 4 Matrix Metalloproteinase (MT4-MMP) and its Different Forms in Melanoma.
    Hieronimus B; Pfohl J; Busch C; Graeve L
    Cell Physiol Biochem; 2017; 42(1):198-210. PubMed ID: 28531887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase A-mediated phosphorylation of naked cuticle homolog 2 stimulates cell-surface delivery of transforming growth factor-α for epidermal growth factor receptor transactivation.
    Cao Z; Singh B; Li C; Markham NO; Carrington LJ; Franklin JL; Graves-Deal R; Kennedy EJ; Goldenring JR; Coffey RJ
    Traffic; 2019 May; 20(5):357-368. PubMed ID: 30941853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MT4-MMP: The GPI-Anchored Membrane-Type Matrix Metalloprotease with Multiple Functions in Diseases.
    Yip C; Foidart P; Noël A; Sounni NE
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30654475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proximal events in signaling by plasma membrane estrogen receptors.
    Razandi M; Pedram A; Park ST; Levin ER
    J Biol Chem; 2003 Jan; 278(4):2701-12. PubMed ID: 12421825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptin stimulates the proliferation of human oesophageal adenocarcinoma cells via HB-EGF and Tgfalpha mediated transactivation of the epidermal growth factor receptor.
    Ogunwobi OO; Beales IL
    Br J Biomed Sci; 2008; 65(3):121-7. PubMed ID: 18986098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases.
    Chabottaux V; Sounni NE; Pennington CJ; English WR; van den Brûle F; Blacher S; Gilles C; Munaut C; Maquoi E; Lopez-Otin C; Murphy G; Edwards DR; Foidart JM; Noël A
    Cancer Res; 2006 May; 66(10):5165-72. PubMed ID: 16707440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells.
    Song RX; Zhang Z; Chen Y; Bao Y; Santen RJ
    Endocrinology; 2007 Aug; 148(8):4091-101. PubMed ID: 17525128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Mechanisms Driven by MT4-MMP in Cancer Progression.
    Muñoz-Sáez E; Moracho N; Learte AIR; Collignon A; Arroyo AG; Noel A; Sounni NE; Sánchez-Camacho C
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane type 4 matrix metalloproteinase (MT4-MMP, MMP-17) is a glycosylphosphatidylinositol-anchored proteinase.
    Itoh Y; Kajita M; Kinoh H; Mori H; Okada A; Seiki M
    J Biol Chem; 1999 Nov; 274(48):34260-6. PubMed ID: 10567400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MT4-MMP Modulates the Expression of miRNAs in Breast Cancer Cells.
    Cervantes-Garduño A; Zampedri C; Espinosa M; Maldonado V; Melendez-Zajgla J; Ceballos-Cancino G
    Arch Med Res; 2018 Oct; 49(7):471-478. PubMed ID: 30792164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAMTS4 (aggrecanase-1) activation on the cell surface involves C-terminal cleavage by glycosylphosphatidyl inositol-anchored membrane type 4-matrix metalloproteinase and binding of the activated proteinase to chondroitin sulfate and heparan sulfate on syndecan-1.
    Gao G; Plaas A; Thompson VP; Jin S; Zuo F; Sandy JD
    J Biol Chem; 2004 Mar; 279(11):10042-51. PubMed ID: 14701864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: novel anti-tumor mechanisms of Cannabidiol in breast cancer.
    Elbaz M; Nasser MW; Ravi J; Wani NA; Ahirwar DK; Zhao H; Oghumu S; Satoskar AR; Shilo K; Carson WE; Ganju RK
    Mol Oncol; 2015 Apr; 9(4):906-19. PubMed ID: 25660577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the dimerization interface of membrane type 4 (MT4)-matrix metalloproteinase.
    Sohail A; Marco M; Zhao H; Shi Q; Merriman S; Mobashery S; Fridman R
    J Biol Chem; 2011 Sep; 286(38):33178-89. PubMed ID: 21828052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of the primary tumor microenvironment by transforming growth factor alpha-epidermal growth factor receptor signaling promotes metastasis in an orthotopic colon cancer model.
    Sasaki T; Nakamura T; Rebhun RB; Cheng H; Hale KS; Tsan RZ; Fidler IJ; Langley RR
    Am J Pathol; 2008 Jul; 173(1):205-16. PubMed ID: 18583324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: involvement of integrin receptor α5β1 in the process.
    Sen T; Chatterjee A
    Eur J Nutr; 2011 Sep; 50(6):465-78. PubMed ID: 21170718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.